Top Story

Primary prevention improves colorectal cancer survival over early detection

November 21, 2017

Primary prevention of colorectal cancer through the removal of adenomatous polyps led to greater mortality reductions than early detection of the disease, according to an analysis of data from the PLCO cancer screening trial.

Thus, colorectal cancer screening guidelines should emphasize the importance of primary prevention, according to the researchers.

Meeting News

Causes of immunotherapy-related side effects in cancer require more research

November 21, 2017
NEW YORK — Oncologists and researchers should be more concerned with the lack of available data on the mechanisms of action behind significant…
Meeting News

Majority of women prefer annual screening mammograms, despite potential ‘harms’

November 21, 2017
More than 70% of women would rather get screened for mammograms annually, despite the current U.S. Preventive Services Task Force recommendation that women at average…

ACP: Improving health care price transparency ‘vital’

November 21, 2017
Increasing access to meaningful information, including price, cost and quality data on health care services, can aid in efforts to improve health care price transparency…
In the Journals Plus

Many cancers associated with modifiable risk factors

November 21, 2017
Cigarette smoking, excess body weight and alcohol intake represented the three most prevalent modifiable risk factors for cancer, according to an American Cancer Society…
More Headlines »

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today